British Journal of Psychiatry, published by Cambridge University Press, stands as a pivotal resource in the realm of mental health and psychiatry. With an impressive impact reflected in its Q1 classifications in both Medicine (miscellaneous) and Psychiatry and Mental Health, this esteemed journal ranks 23rd out of 567 in its field according to Scopus, achieving an exceptional 96th percentile. Since its inception in 1963, the journal has continued to push the boundaries of research and discourse, serving as a platform for groundbreaking studies that enhance our understanding of psychiatric conditions and promote effective therapeutic strategies. Though it does not operate with an open-access model, the British Journal of Psychiatry remains an essential publication for researchers, clinicians, and students alike, offering in-depth insights and innovative findings that are crucial for navigating the complexities of mental health.

The JOURNAL OF CLINICAL PSYCHOLOGY, published by Wiley, has been a pivotal resource in the field of psychological research since its inception in 1945. With an impressive impact factor and classification within the Q1 category for both Arts and Humanities and Clinical Psychology, it ranks prominently at #54/552 in Arts and Humanities and #71/311 in Clinical Psychology according to Scopus, placing it in the top percentiles for both categories. The journal primarily serves as a platform for disseminating groundbreaking research, theoretical advancements, and practical applications pertinent to clinical psychology, making it indispensable for researchers, clinicians, and scholars dedicated to enhancing mental health practices. Although not an open-access journal, it provides critical insights and methodologies that are fundamental for professionals navigating the complexities of clinical psychology today. With a commitment to advancing understanding and treatment of psychological disorders, the journal continues to shape outcomes in mental health and therapeutic practices.

PSYCHIATRY AND CLINICAL NEUROSCIENCES is a leading journal in the fields of psychiatry and clinical neurology, published by Wiley. With a commendable impact factor and a position within the prestigious Q1 quartile across multiple relevant categories—including Medicine (Miscellaneous), Neurology, and Psychiatry and Mental Health—this journal stands out for its rigorous peer-reviewed content that addresses critical issues in mental health and neurological disorders. Established in 1933, the journal has a rich history of contributing impactful research that guides both clinical practice and academic inquiry. Although it is not an open-access journal, its high relevance is underscored by its Scopus rankings, with notable percentiles in Psychiatry and Neurology, making it a vital resource for researchers, clinicians, and students looking to stay abreast of the latest advancements. Located in the United Kingdom, PSYCHIATRY AND CLINICAL NEUROSCIENCES aims to bridge the gap between theory and practical application, fostering a comprehensive understanding of the complex interplay between mental health and neurological conditions.

Rivista di Psichiatria, published by PENSIERO SCIENTIFICO EDITORE, stands as a significant contributor to the field of Psychiatry and Mental Health since its inception in 1975. With an ISSN of 0035-6484 and an E-ISSN of 2038-2502, this esteemed journal offers a platform for rigorous academic discourse and cutting-edge research, helping to shape contemporary psychiatric practices and theories. Currently holding a Q2 designation in Psychiatry and Mental Health based on the 2023 category quartiles, and ranking #197 out of 567 in Scopus, it reflects a commendable 65th percentile among its peers. The journal welcomes contributions that encompass a broad range of topics related to mental health, encouraging contributions from a multidisciplinary approach, which aids in its goal of advancing the understanding and application of psychiatric science. While it is a traditional journal without Open Access options, access to its valuable content can support researchers, clinicians, and students in their pursuit of knowledge and innovation within the field. Situated in Rome, Italy, at VIA SAN GIOVANNI VALDARNO 8, ROME 00138, the journal continues to enhance its rich legacy, promoting the exchange of ideas and fostering collaboration amongst practitioners and scholars alike.

BJPsych Open, published by Cambridge University Press, is a leading open access journal dedicated to the field of psychiatry and mental health. Since its inception in 2015, the journal has provided a platform for disseminating cutting-edge research and evidence-based practices, making significant contributions to the academic community. With an impressive impact factor and currently ranking in the top Q1 quartile of its field, BJPsych Open is recognized for its rigor and relevance, ranking 138 out of 567 journals in psychiatry and mental health according to Scopus, placing it in the 75th percentile. The journal's commitment to open access enhances visibility and accessibility, ensuring that vital research is available to a global audience. Researchers, professionals, and students alike will find valuable insights into contemporary mental health challenges and innovative treatment approaches, making BJPsych Open an essential resource for advancing mental health scholarship.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE is a distinguished publication in the field of Psychiatry and Mental Health, published by TAYLOR & FRANCIS LTD in the United Kingdom. With an impressive 2023 impact factor that places it in the Q2 category among its peers, this journal is an essential resource for researchers, clinicians, and students dedicated to advancing mental health practices and understanding psychiatric disorders. Covering topics from clinical studies to innovative treatment methodologies, the journal welcomes original research, reviews, and case studies that contribute valuable insights into clinical practice. Accessible without any open access restrictions, the journal has been a pivotal platform since its inception in 1997, facilitating knowledge exchange in the field up to 2024. As evidenced by its notable Scopus ranking within the top 73rd percentile of Psychiatry and Mental Health, it remains committed to impacting clinical practices significantly.

PSYCHONEUROENDOCRINOLOGY is a leading journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing the understanding of the interplay between psychological, neurological, and endocrine systems. Since its inception in 1975, the journal has emerged as a critical resource for researchers in fields such as biological psychiatry, endocrinology, and neuroscience, achieving prestigious quartile rankings including Q1 in Endocrine and Autonomic Systems and Q1 in Psychiatry and Mental Health as of 2023. With a strong focus on original research and comprehensive reviews, PSYCHONEUROENDOCRINOLOGY fosters an engaging platform for the exchange of innovative ideas, findings, and methodologies. Although not an open access journal, it provides broad access through institutional subscriptions, making it an invaluable asset for students, professionals, and researchers alike, keen to delve into the latest developments in this interdisciplinary field. With an impressive Scopus ranking and high percentiles across multiple categories, this journal stands at the forefront of scientific inquiry pertaining to the intricate relationships between mind and body, paving the way for novel therapeutic approaches and enhancing our understanding of mental health disorders.

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

BJPsych Advances is a distinguished journal dedicated to the field of Psychiatry and Mental Health, published by Cambridge University Press. With an ISSN of 2056-4678 and an E-ISSN of 2056-4686, this journal serves as a crucial platform for disseminating high-quality research and advancements in psychiatric science. Holding a position in the Q3 quartile as of 2023, it ranks 330 out of 567 in the Scopus database, representing a significant contribution to the mental health community, with a 41st percentile status. The journal not only covers recent innovations and methodologies but also emphasizes practical applications in clinical settings, making it an essential resource for researchers, practitioners, and students alike. With a commitment to fostering a deeper understanding of psychiatric disorders and their implications, BJPsych Advances plays a vital role in enhancing the standards of mental healthcare across the globe, bridging the gap between academic research and clinical practice.

Alpha Psychiatry, published by AVES, stands at the forefront of mental health research and psychiatric advancements. With a commitment to disseminating high-quality and impactful studies, this journal serves as a critical platform for scholars, clinicians, and students interested in exploring the complexities of psychiatric disorders and treatment methodologies. Although the impact factor and specific scope details are still evolving, Alpha Psychiatry is dedicated to fostering interdisciplinary dialogue and promoting innovative research that tackles contemporary challenges in the field of psychiatry. As an open-access journal, it ensures that research is widely accessible, enhancing knowledge transfer and collaboration within the global scientific community. Located in Istanbul, Turkiye, the journal proudly represents a rich academic tradition, aiming to contribute significantly to the global discourse on mental health.